Citigroup Maintains Neutral on Nevro, Lowers Price Target to $16
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Joanne Wuensch has maintained a Neutral rating on Nevro (NYSE:NVRO) and reduced the price target from $18 to $16.
April 03, 2024 | 3:56 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Citigroup has maintained a Neutral rating on Nevro and lowered the price target from $18 to $16.
The reduction in price target by Citigroup, a major financial institution, could lead to a negative short-term sentiment among investors, potentially causing a decrease in NVRO's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100